Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 10:00 am Purchase | 2025-09-30 | 13G | Xilio Therapeutics, Inc. XLO | StemPoint Capital LP | 4,000,000 7.200% | 4,000,000 (New Position) | Filing History |
| 2025-08-14 10:37 am Purchase | 2025-06-30 | 13G | Surrozen, Inc. SRZN | StemPoint Capital LP | 1,016,197 11.400% | 445,713 (+78.13%) | Filing History |
| 2025-05-15 12:00 pm Purchase | 2025-03-31 | 13G | Surrozen, Inc. SRZN | StemPoint Capital LP | 570,484 15.800% | 85,253 (+17.57%) | Filing History |
| 2025-02-14 1:03 pm Purchase | 2024-12-31 | 13G | Surrozen, Inc. SRZN | StemPoint Capital LP | 485,231 14.300% | 57,455 (+13.43%) | Filing History |
| 2025-02-14 1:01 pm Purchase | 2024-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | StemPoint Capital LP | 2,328,492 8.200% | 538,310 (+30.07%) | Filing History |
| 2024-11-01 12:42 pm Purchase | 2024-10-31 | 13G | Surrozen, Inc. SRZN | StemPoint Capital LP | 427,776 12.800% | 427,776 (New Position) | Filing History |
| 2024-02-12 6:27 pm Purchase | 2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | StemPoint Capital LP | 1,790,182 6.500% | 1,790,182 (New Position) | Filing History |